Over-the-counter triptans for migraine : what are the implications?

  title={Over-the-counter triptans for migraine : what are the implications?},
  author={Peer Carsten Tfelt-Hansen and T J Steiner},
  journal={CNS drugs},
  volume={21 11},
In 2006, the triptans sumatriptan 50mg and naratriptan 2.5mg were approved as over-the-counter (OTC) drugs in pharmacies in the UK and Germany, respectively. Both drugs have been used in a large number of patients with migraine and are considered to have good safety profiles. The implications of OTC triptan availability for clinical practice are that more migraine patients will use a triptan and will tend to medicate early when their headache is still mild, which should be beneficial. The… CONTINUE READING